2 news items
Cogent Biosciences Announces Positive Updated Lead-In Data from Ongoing Phase 3 PEAK Trial Evaluating Bezuclastinib in Combination with Sunitinib in Patients with Gastrointestinal Stromal Tumors (GIST) at ASCO Annual Meeting
COGT
23 May 24
ConferenceCogent will participate in the Jefferies Global Healthcare Conference on Wednesday, June 5 at 2:30 p.m. ET. A live webcast
Marinus Pharmaceuticals, Neumora Therapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session
COGT
MOH
MRNS
15 Apr 24
(NASDAQ:PSNY) shares fell 7.2% to $1.35 in pre-market trading.
Molina Healthcare, Inc
- Prev
- 1
- Next